Bristol-Myers Squibb Company
METHODS OF TREATING EARLY RHEUMATOID ARTHRITIS

Abstract:

The present invention is directed to methods and compositions for achieving drug-free remission in subjects with early RA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule until Disease Activity Score Calculator for Rheumatoid Arthritis (DAS)-defined remission is achieved and then withdrawing the RA therapy.